Rapid Test Coronavirus COVID-19 OF ANTIGEN OF SARS-CoV-2 INVIMA
- Results In 15 Minutes - Rapid immunochromatographic test for qualitative detection of the antigen of the nucleocapsid protein of the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in human nasopharyngeal swab samples as an aid for the rapid diagnosis of infection by coronavirus (COVID-19).
The test is performed by placing the extracted sample in the sample well (S) of the cassette and observing the formation of colored lines. The SARS-CoV-2 nucleocapsid protein antigen is detected using highly sensitive monoclonal antibodies. The sample migrates by capillary effect along the membrane. If present in the sample, the SARS-CoV-2 antigen reacts with the conjugated colloidal gold particles of the monoclonal antibody and is captured by secondary monoclonal antibodies immobilized in the test region (T). A colored line will form in the test region (T). The presence of this line indicates a positive result, while its absence indicates a negative result. As a procedural control, a colored line should appear in the control region (C).



• Minimum sale Box X25 Units. Unit Value $ 38,000

 Storage: 2-30 ° C, protected against humidity, light and heat

• Sensitivity: 97.3% - Specificity: 100% - Relative Accuracy: 98.8%

• Sample: Nasopharyngeal swab

• Invima registration

• Reading: Visual

• Made in Austria